Novo Nordisk A/S (NOVO-B)’in fiyatı nedir?

Novo Nordisk A/S (NOVO-B)’in fiyatı $44.42’dir

Novo Nordisk A/S (NOVO-B)’in piyasa değeri nedir?

Novo Nordisk A/S (NOVO-B)’in piyasa değeri $197.32B’dir.

Novo Nordisk A/S (NOVO-B) Faaliyet Marjı

Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.

Yıl	Faaliyet Marjı	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Faaliyet Marjı

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Faaliyet Marjı	Faaliyet Marjı Farkı	Ülke
Eli Lilly and Company LLY.US	43.92%	-98.96%	US
Johnson & Johnson JNJ.US	26.81%	-99.36%	US
AbbVie Inc. ABBV.US	29.32%	-99.30%	US
Roche Holding AG RO.SW	26.59%	-99.37%	CH
Merck & Co., Inc. MRK.US	16.65%	-99.60%	US

Şirket

Faaliyet Marjı

Faaliyet Marjı Farkı

Ülke